Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Apr 10 17:33 ET
Cadrenal Therapeutics | 8-K: Current report
Apr 9 09:30 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cole Jeffrey Scott
Apr 3 17:25 ET
Cadrenal Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cole Jeffrey Scott
Apr 3 17:24 ET
Cadrenal Therapeutics | EFFECT: Others
Apr 3 06:07 ET
Cadrenal Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Apr 2 12:58 ET
Cadrenal Therapeutics | EFFECT: Others
Mar 21 06:06 ET
Cadrenal Therapeutics | CORRESP: CORRESP
Mar 18 12:54 ET
Cadrenal Therapeutics | UPLOAD: Others
Mar 15 12:54 ET
Cadrenal Therapeutics | 8-K: Current report
Mar 12 12:54 ET
Cadrenal Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 12 08:42 ET
Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Mar 12 08:07 ET
Cadrenal Therapeutics | 10-K: Annual report
Mar 11 12:58 ET
Cadrenal Therapeutics | 8-K: Current report
Mar 11 09:16 ET
Cadrenal Therapeutics | 8-K: Current report
Mar 5 17:31 ET
Cadrenal Therapeutics | 8-K/A: Current report (Amendment)
Feb 15 08:07 ET
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:39 ET
Cadrenal Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Raymond Murphy(5.49%)
Feb 13 17:32 ET
Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Quang X. Pham(48.57%),The PVBQ Living Trust(23.04%)
Feb 12 21:45 ET
Cadrenal Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pham Quang X
Feb 12 21:45 ET
No Data
No Data